In this Issue:
No place for aspirin in primary prevention
Glycemic index and overweight patients
Cholesterol efflux capacity and CV events
Emerging role of microRNAs in CV disease
Effects of intensive glycaemic control on IHD
An economic case for a polypill?
CV risk in patients with sleep apnoea
Angiotensin II receptor blockers and cancer
Statin loading prior to PCI decreases CV events
National trends in stroke after acute MI
Please login below to download this issue (PDF)